Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide

201984 citationsJournal Articlehybrid Open Access

Authors

Alessandro Muzzi · GlaxoSmithKline (India)

Alessandro Brozzi · GlaxoSmithKline (India)

Laura Serino · GlaxoSmithKline (India)

Margherita Bodini · GlaxoSmithKline (India)

Raquel Abad · Instituto de Salud Carlos III

Dominique A. Caugant · Norwegian Institute of Public Health

Maurizio Comanducci

Abstract

gMATS can replace MATS in predicting 4CMenB strain coverage in four out of five cases, without requiring a cultivable isolate, and is open to further improvement. Both methods underestimated VE in England. Strain coverage predictions in other countries matched or exceeded England and Wales estimates.

Topics & Keywords

Bacterial Infections and Vaccines Pneumonia and Respiratory Infections Respiratory viral infections research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Vaccine

Volume 37, Issue 7, pp. 991-1000

DOI: 10.1016/j.vaccine.2018.12.061

Field-Weighted Citation Impact: 8.82